Compass Rose Behavioral Health was established to guide and support your unique life journey by helping you discover yourself, and your purpose as your life changes directions. I believe orthodox ...

Compass Pathways is developing therapies for ... During this quarter, the company's R&D expenses rose to $29.1 million, up from $19.8 million in Q2 2023. This was largely due to the ongoing ...

Compass had a negative return on equity of 39.72% and a negative net margin of 2.74%. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.38 billion.

Compass ended 2024 with $127 million in cash and marketable securities, which it expects will fund operations into Q1 2027. R&D expenses rose 11% YoY to $42.3 million in 2024, primarily due to ...

Revenue soared 25.9% in Q4 to $1.38 billion, matching the consensus, while transaction value rose 24.1%, which was 3.5 times faster than the overall market. Compass's market share improved 65 ...

Compass ended 2024 with $127 million in cash and marketable securities, which it expects will fund operations into Q1 2027. R&D expenses rose 11% YoY to $42.3 million in 2024, primarily due to ...